Biomarkers for acute kidney injury in decompensated cirrhosis: A prospective study.
David A JaquesLaurent SpahrGregory BerraVincent PoffetPierre LescuyerEric GerstelNicolas GarinPierre-Yves MartinBelen PontePublished in: Nephrology (Carlton, Vic.) (2019)
In patients with decompensated cirrhosis, early measurement of renal biomarkers provides valuable information on AKI aetiology. It could also improve AKI diagnosis and prognosis.